Inovio’s coronavirus vaccine, funded by Bill Gates, begins human trials
pharmafile | April 7, 2020 | News story | Manufacturing and Production | COVID-19, coronavirus, coronavirus vaccine
Inovio’s coronavirus vaccine has entered human trials after the FDA approved its application to begin them under the Investigational New Drug program. The research has been partly funded by The Bill and Melinda Gates Foundation.
The FDA approval comes after promising results in animal testing. The INO-4800 DNA vaccine began being used in trials on Monday, with 40 volunteers receiving their first dose, which will be followed by a second in four weeks’ time.
The Phase I clinical trial is to establish the treatments safety and the immunogenicity of the vaccine. The Phase II trial will test its effectiveness in combating COVID-19.
Inovio has manufactured thousands of doses of their vaccine to support the upcoming trials. The company is far ahead of the competition in getting a working vaccine into circulation, and a spokesperson for the company said that a vaccine had been developed three hours after the release of the viral sequence of SARS-CoV-2 on 10 January.
Depending on the trials success, the company could have millions of doses ready by the end of the year for further testing or emergency treatments. However, regulatory approval will likely take another 12 to 18 months.
As well as the funding from The Bill and Melinda Gates Foundation, the company also received finances from the Coalition for Epidemic Preparedness Innovations (CEPI). The CEPI have also giving funding to five other potential vaccines.
Conor Kavanagh
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, …
